BMC Pediatr

1. GEBREKIDAN RT, Weldu AH, Teklemedhin SW, Teka HE, et al
   Utilization and associated factors of second dose measles vaccine among mothers having a child less than two years old in Enderta District, South Eastern Tigray, Ethiopia.
   BMC Pediatr. 2025 Dec 19. doi: 10.1186/s12887-025-06436.
   

   >> Share

   
   

   
   BMJ

2. BARANIUK C
   Flu: Extra jabs ordered by wholesalers as UK demand for vaccines soars.
   BMJ. 2025;391:r2652.
   

   >> Share

   
   
3. REICHER S, McKee M, Griffin S
   Vaccinate, isolate, ventilate: will we finally learn the lessons from covid this flu season?
   BMJ. 2025;391:r2638.
   

   >> Share

   
   

   
   Clin Infect Dis

4. HELLNER K, Simon P, De Sutter P, Vahula KL, et al
   A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women w
   Clin Infect Dis. 2025 Dec 17:ciaf658. doi: 10.1093.
   

   >> Share

   
   

   
   Infect Immun

5. ZHU Z, Xu J, Yang J, Tian H, et al
   Klebsiella pneumoniae ghosts as a novel adjuvant drive dendritic cell maturation and antigen-specific TCM expansion for IFN-gamma-mediated immune protection.
   Infect Immun. 2025;93:e0033525.
   

   >> Share

   
   

   
   J Infect Dis

6. BROSHKEVITCH CJ, Giuliano AR, Palefsky JM, Nahhas G, et al
   Assessment of Concordant Human Papillomavirus Infection With 9-Valent Vaccine Types Across Anogenital Sites in Young Men.
   J Infect Dis. 2025 Dec 16:jiaf564. doi: 10.1093.
   

   >> Share

   
   

   
   JAMA

7. PANT S
   Shingles Vaccine May Slow Dementia Progression.
   JAMA. 2025 Dec 19. doi: 10.1001/jama.2025.20027.
   

   >> Share

   
   
8. GOSTIN LO, Reiss D
   State Vaccine Law and Policy-A New Threat to Public Health.
   JAMA. 2025 Dec 18. doi: 10.1001/jama.2025.25904.
   

   >> Share

   
   
9. MCCLYMONT E, Blitz S, Forward L, Cole S, et al
   The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy.
   JAMA. 2025 Dec 15:e2521001. doi: 10.1001/jama.2025.21001.
   

   >> Share

   
   

   
   Nat Med

10. POLISKY V, Littmann M, Triastcyn A, Horn M, et al
    Varicella-zoster virus reactivation and the risk of dementia.
    Nat Med. 2025;31:4172-4179.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

11. HERNAN MA, Alvaro-Meca A, Calvo-Alcantara MJ, Navarro Gomez ML, et al
    Effectiveness and Safety of COVID-19 mRNA Vaccines in Children 6-17 Years Old: A Population-Based Study in Madrid.
    Pediatr Infect Dis J. 2025 Dec 16. doi: 10.1097/INF.0000000000005109.
    

    >> Share

    
    

    
    PLoS One

12. OH YJ, Rasul ME, Lim JI, Calabrese C, et al
    Targeting anger for COVID-19 prevention: The motivating role of anger on media use and vaccination intention.
    PLoS One. 2025;20:e0338183.
    

    >> Share

    
    
13. BARDACH A, Berrueta M, Ciapponi A, Sambade JM, et al
    Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates.
    PLoS One. 2025;20:e0338128.
    

    >> Share

    
    
14. ARAUJO JIF, Batista FAM, De Souto Medeiros MR, Sena BO, et al
    The use of social media as an influence on vaccination rates: A systematic review protocol.
    PLoS One. 2025;20:e0334114.
    

    >> Share

    
    
15. GYAWALI N, Caragea D, Caragea C, Mohammad SM, et al
    The shifting landscape of vaccine discourse: Insights from a decade of pre- to post-COVID-19 vaccine posts on social media.
    PLoS One. 2025;20:e0337911.
    

    >> Share

    
    

    
    Vaccine

16. MUKHERJEE A, Das S, Mandal S, Roy N, et al
    Safety, immunogenicity and preliminary protective efficacy of a bivalent bacterial ghost vaccine against typhoidal Salmonella in rabbits: a pilot study.
    Vaccine. 2025;72:128126.
    

    >> Share

    
    
17. KHAN S, McWhorter AR, Andrews DM, Underwood GJ, et al
    An enhanced vaccination regime reduces the shedding of Salmonella Typhimurium from layer chickens.
    Vaccine. 2025;72:128115.
    

    >> Share

    
    
18. CHEN Y, Liu Q, Wang C, Chen S, et al
    Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models.
    Vaccine. 2025;72:128136.
    

    >> Share

    
    
19. KAYESH MEH, Kohara M, Tsukiyama-Kohara K
    Carboxy-vinyl polymer: A promising immunostimulant for vaccines targeting respiratory and internal organ viruses.
    Vaccine. 2025;72:128146.
    

    >> Share

    
    
20. WANG L, Li L, Yang W, Pang X, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6-35 months: A multi-center, randomized, double-blind, active-controlled clinical trial.
    Vaccine. 2025;71:128113.
    

    >> Share

    
    
21. NKEREUWEM O, Jallow AO, Jallow DN, Owolabi J, et al
    Acceptance of a newly introduced COVID-19 vaccine among pregnant women and their decision influencers: a qualitative study in The Gambia.
    Vaccine. 2025;71:128070.
    

    >> Share

    
    
22. COAD S, Liebermann EJ, Lim E, Matsunaga M, et al
    Does changing the routinely recommended age for HPV vaccination change parental thoughts about vaccinating their adolescent: A mixed-methods analysis.
    Vaccine. 2025;71:128080.
    

    >> Share

    
    
23. HAYASHI K, Hashimoto N, Hashimoto C, Takeuchi Y, et al
    Effect of completed COVID-19 vaccination on serum interferon lambda3: a single-center retrospective study.
    Vaccine. 2025;72:128108.
    

    >> Share

    
    
24. NOGUCHI S, Ishimaru T, Yatera K, Machida M, et al
    Factors associated with respiratory syncytial virus vaccination among Japanese adults aged 60 years and older: an internet-based cross-sectional study.
    Vaccine. 2025;71:128114.
    

    >> Share

    
    
25. DROBIC B, Akintunde G, Kim J, Mirceta M, et al
    Immunogenicity, safety, and lot consistency of the anthrax vaccine adsorbed, adjuvanted for post-exposure prophylaxis of anthrax in healthy adults: A phase 3, randomized, double-blind trial.
    Vaccine. 2025;72:128068.
    

    >> Share

    
    
26. YU S, Zheng B, Zhao J, Jiang L, et al
    Vaccine fatigue, perceived risk and trust: Unraveling the motivational drivers of influenza vaccination in Chinese adults using the COM-B model.
    Vaccine. 2025;72:128112.
    

    >> Share

    
    
27. CARRICO J, McGuiness C, Yasuda M, Chen CC, et al
    Herpes zoster vaccination among immunocompromised adults in the United States.
    Vaccine. 2025;72:128124.
    

    >> Share

    
    
28. ZHANG X, Chen S, Tang S
    Closing the immunization gap: Overcoming barriers for new vaccine introduction in Southeast and South Asia.
    Vaccine. 2025;72:128119.
    

    >> Share

    
    
29. RAHMAN L, Gao T, Nam J, Zeng Y, et al
    The effect of digital interventions on the uptake of HPV vaccination in the United States: A systematic review and meta-analysis.
    Vaccine. 2025;71:128117.
    

    >> Share

    
    
30. DE OLIVEIRA NR, Maia MAC, Kremer FS, Moreira ADL, et al
    Whole-genome sequencing as a regulatory tool for quality control of Leptospira strains for vaccines and diagnostics.
    Vaccine. 2025;71:128110.
    

    >> Share

    
    
31. BOCQUIER A, Cadoret S, Fall E, Bonnay S, et al
    Process evaluation of a school-based vaccination intervention to improve HPV vaccine coverage: A mixed-method study embedded in the French PrevHPV cluster randomized controlled trial.
    Vaccine. 2025;72:128122.
    

    >> Share

    
    
32. GSCHWEND MH, Faust E, Rousculp MD, Toback S, et al
    The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences.
    Vaccine. 2025;72:128120.
    

    >> Share

    
    
33. MADIA JE, Nicodemo C, Petrou S, de Lusignan S, et al
    Primary healthcare costs associated with the AstraZeneca COVID-19 vaccine in England.
    Vaccine. 2025;72:128067.
    

    >> Share

    
    
34. TOMOI H, Hanley SJB, Larson HJ, Tomoi H, et al
    Determinants of human papillomavirus vaccination decision-making in Japan: a scoping review exploring contextual, social, and adolescent-specific influences.
    Vaccine. 2025;72:128111.
    

    >> Share

    
    
35. NAGUIB M, Comfort SO, Renukaradhya GJ, Sharma S, et al
    Mucosal delivery (in ovo and oral) of chitosan nanoparticle-based subunit vaccine enhances resistance against Campylobacter jejuni colonization in broiler chickens.
    Vaccine. 2025;72:128116.
    

    >> Share

    
    

    
    Virus Res

36. IANKOV I, Ammayappan A, Viker K, Weisend C, et al
    Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagent.
    Virus Res. 2025 Dec 15:199676. doi: 10.1016/j.virusres.2025.199676.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share